Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ)

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  von Baum, Heike ^a   Welte, Tobias ^b   Marre, Reinhard ^a   Suttorp, Norbert ^c   Lück, Christian ^d   Ewig, Santiago ^e  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e Thoraxzentrum Ruhrgebiet ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN M; KETOLIDE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ANTIBODY TITER; ARTICLE; ARTIFICIAL VENTILATION; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONFUSION; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DYSPNEA; FEMALE; FEVER; GERMANY; HUMAN; INCIDENCE; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; OUTCOME ASSESSMENT; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; SYMPTOMATOLOGY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; AGED; ANALYSIS OF VARIANCE; CHI SQUARE DISTRIBUTION; COMMUNICABLE DISEASE; ENZYME IMMUNOASSAY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; PUBLIC HEALTH;

ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GERMANY; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; PUBLIC HEALTH;

EID: 66949117521     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-62     Document Type: Article

References (26)

1. Foy HM Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients Clin Infect Dis 1993, 17 Suppl 1:37-46
2. Waites KB Talkington DF Mycoplasma pneumoniae and its role as a human pathogen Clin Microbiol Rev 2004, 17:697-728. 523564 15489344 10.1128/ CMR.17.4.697-728.2004
3. Arnold FW Summersqill JT Lajoje AS Pevrani P Marrie TJ Rossi P Blasi F Fernandez P File TM Jr Rello J et al A worldwide perspective of atypical pathogens in community-acquired pneumonia Am J Respir Crit Care Med 2007, 175:1086-93. 10.1164/rccm.200603-350OC 17332485
4. Welte T Suttorp N Marre R CAPNETZ-community-acquired pneumonia competence network Infection 2004, 32:234-38. 10.1007/s15010-004-3107-z 15293080
5. von Baum H Ewig S Marre R Suttorp N Gonschior S Welte T Lück C Competence Network for Community-Acquired Pneumonia Study Group Community Acquired Legionella Pneumonia - New Insights from the German competence network CAPNETZ Clin Inf Dis 2008, 46:1356-64. 10.1086/586741
6. Mauch H Wagner J Marklein G Kühnen E Albert S Schuster L Freidank H Molitor E Müller K-D Kästli K et al. MIQ 7&8. Infektionen der tiefen Atemwege Teil I und II. Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik Gustav-Fischer-Verlag; Jena, Germany 1999
7. Wellinghausen N Straube E Freidank H von Baum H Marre R Essig A Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia Int J Med Microbiol 2006, 296:485-91. 10.1016/ j.ijmm.2006.05.003 16890487
8. Dumke R Schurwanz N Lenz M Schuppler M Lück C Jacobs E Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach J Clin Microbiol 2007, 45:2726-30. 1951254 17537933 10.1128/JCM.00321-07
9. Berntsson E Blomberg J Lagergard T Trollfors B Etiology of community-acquired pneumonia in patients requiring hospitalization Eur J Clin Microbiol 1985, 4:268-72. 10.1007/BF02013650 4018066
10. Woodhead MA Macfarlane JT Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias Br J Dis Chest 1987, 81:133-39. 10.1016/0007-0971(87)90130-6 3651306
11. Marrie TJ Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly Arch Intern Med 1993, 153:488-94. 10.1001/archinte.153.4.488 8435028
12. Marrie TJ Poulin-Costello M Beecroft MD Herman-Gnjidic Z Etiology of community-acquired pneumonia treated in an ambulatory setting Respir Med 2005, 99:60-5. 10.1016/j.rmed.2004.05.010 15672850
13. Lieberman D Schlaeffer F Horowitz S Horovitz O Porath A Mycoplasma pneumoniae community-acquired pneumonia: A review of 101 hospitalized adult patients Respiration 1996, 63:261-66. 10.1159/000196557 8884996
14. Bochud PY Moser F Erard P Verdon F Studer JP Villard G Cosendai A Cotting M Heim F Tissot J et al Community-acquired pneumonia. A prospective outpatient study Medicine 2001, 80:75-87B. 10.1097/ 00005792-200103000-00001 11307590
15. Beersma MFC Dirven K van Dam AP Templeton KE Claas ECJ Goossens H Evaluation of 12 commercial tests and the Complement Fixation Test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "Gold Standard" J Clin Microbiol 2005, 43:2277-85. 1153783 15872256 10.1128/ JCM.43.5.2277-2285.2005
16. Daxboeck F Krause R Wenisch C Laboratory diagnosis of Mycoplasma pneumoniae infection Clin Microbiol Infect 2003, 9:263-73. 10.1046/ j.1469-0691.2003.00590.x 12667235
17. Loens K Ursi D Goossens H Leven M Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections J Clin Microbiol 2003, 41:4915-23. 262541 14605118 10.1128/JCM.41.11.4915-4923.2003
18. Ruiz M Ewig S Marcos MA Martinez JA Arancibia F Mensa J Torres A Etiology of community-acquired pneumonia: Impact of age, comorbidity, and severity Am J Respir Crit Care Med 1999, 160:397-405. 10430704
19. Weigl JA Puppe W Meyer CU Berner R Forster J Schmitt HJ Zepp F Ten years' experience with year-round active surveillance of up to 19 respiratory pathogens in children Eur J Pediatr 2007, 166:957-66. 10.1007/s00431-007-0496-x 17569085
20. Mills GD Oehley MR Arrol B Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: Meta-analysis BMJ 2005, 330:456. 549658 15684024 10.1136/bmj.38334.591586.82
21. Gleason PP Meehan TP Fine JM Galusha DH Fine MJ Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia Arch Intern Med 1999, 159:2562-72. 10.1001/archinte.159.21.2562 10573046
22. Dudas V Hopfel A Jacobs R Guglielmo BJ Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: A survey of nonteaching US community hospitals Ann Pharmacother 2000, 34:446-52. 10.1345/aph.19174 10772428
23. Frei CR Koeller JM Burgess DS Talbert RL Johnsrud MT Impact of atypical coverage for patients with community-acquired pneumonia managed on the medical ward: Results from the United States Community-Acquired Pneumonia Project Pharmacotherapy 2003, 23:1167-74. 10.1592/ phco.23.10.1167.32764 14524648
24. Houck PM MacLehose RF Niederman MS Lowery JK Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 western states: 1993, 1995, and 1997 Chest 2001, 119:1420-26. 10.1378/chest.119.5.1420 11348948
25. Burgess DS Lewis JS 2nd Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia Clin Ther 2000, 22:872-78. 10.1016/ S0149-2918(00)80059-4 10945513
26. Mandell LA Wunderink RG Anzueto A Bartlett JG Campbell GD Dean NC Dowell SF File TM Jr Musher DM Niederman MS et al Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 2007 44 Suppl 2 S27 72 10.1086/511159 17278083